Mesothelioma Treatment for victims can have more hope for regenerative treatments with the latest discovery of a cancer drug that’s proving to have multi-faceted benefits in treatments against mesothelioma. One leading mesothelioma and asbestos cancer resource site, reported that the research conducted was uplifting. The Medical University of Vienna recently published that the drug: Temsirolimus, a cancer drug originally developed to treat kidney cancer, has been able to slow the growth of malignant pleural mesothelioma cells in patients.
Since it’s original design was to slow tumor growth in kidney cancer and renal cell carcinoma, it’s dual-ability in slowing cell growth by blocking mTOR-medicated signals has proven very beneficial. This along with other recent alternative treatment procedure and several research projects that have recently been awarded a collective $700K by the Mesothelioma Applied Research Foundation (Meso Foundation), Mesothelioma victims can be assured that this rare asbestos cancer is aggresively being persued for restorative treatments and cures.
.jpg)
